Veerhealth Care Standalone December 2020 Net Sales At Rs 3.85 Crore, Up 72.7% Y-o-Y

Veerhealth Care standalone net profit declines 44.44% in the December 2020 quarter

Price return has been average, nothing exciting

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

The stock has a moderate number of red flags

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Veerhealth Care is engaged in manufacturing and marketing research-based Ayurvedic medicines. The Company's product categories include Tablets, Syrups, Ointments, Powder, Oil and Toothpaste.

Veerhealth Care Ltd

Veerhealth Care Ltd

Scorecard

News & Opinions

Veerhealth Care Standalone December 2020 Net Sales At Rs 3.85 Crore, Up 72.7% Y-o-Y

Veerhealth Care standalone net profit declines 44.44% in the December 2020 quarter